ATE434624T1 - Ul16-bindungsprotein 4 - Google Patents

Ul16-bindungsprotein 4

Info

Publication number
ATE434624T1
ATE434624T1 AT02778459T AT02778459T ATE434624T1 AT E434624 T1 ATE434624 T1 AT E434624T1 AT 02778459 T AT02778459 T AT 02778459T AT 02778459 T AT02778459 T AT 02778459T AT E434624 T1 ATE434624 T1 AT E434624T1
Authority
AT
Austria
Prior art keywords
ulbp4
binding protein
cells
encoding
vectors
Prior art date
Application number
AT02778459T
Other languages
German (de)
English (en)
Inventor
David Cosman
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE434624T1 publication Critical patent/ATE434624T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT02778459T 2001-10-04 2002-10-04 Ul16-bindungsprotein 4 ATE434624T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32725201P 2001-10-04 2001-10-04
PCT/US2002/031994 WO2003029436A2 (en) 2001-10-04 2002-10-04 Ul16 binding protein 4

Publications (1)

Publication Number Publication Date
ATE434624T1 true ATE434624T1 (de) 2009-07-15

Family

ID=23275763

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02778459T ATE434624T1 (de) 2001-10-04 2002-10-04 Ul16-bindungsprotein 4

Country Status (10)

Country Link
US (2) US7563450B2 (https=)
EP (1) EP1451333B1 (https=)
JP (1) JP2005523681A (https=)
AT (1) ATE434624T1 (https=)
AU (1) AU2002340118B2 (https=)
CA (1) CA2462790A1 (https=)
DE (1) DE60232742D1 (https=)
MX (1) MXPA04003057A (https=)
PL (1) PL373594A1 (https=)
WO (1) WO2003029436A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2483343A1 (en) * 2002-04-22 2003-10-30 Fred Hutchinson Cancer Research Center Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions
WO2004022706A2 (en) * 2002-09-04 2004-03-18 The Trustees Of The University Of Pennsylvania Immune cell receptor ligand and immune cell receptor
US7666417B2 (en) * 2003-04-22 2010-02-23 Fred Hutchinson Cancer Research Center Methods and compositions for treating autoimmune diseases or conditions
ATE496944T1 (de) * 2003-07-21 2011-02-15 Immunogen Inc Ca6-antigenspezifisches zytotoxisches konjugat und verfahren zu dessen anwendung
US7834155B2 (en) 2003-07-21 2010-11-16 Immunogen Inc. CA6 antigen-specific cytotoxic conjugate and methods of using the same
US7998481B2 (en) 2004-04-05 2011-08-16 The Regents Of The University Of California Modulation of NKG2D for treating or preventing solid organ allograft rejection
DE102004042894A1 (de) * 2004-08-30 2006-03-02 Eberhard-Karls-Universität Tübingen Verwendung von Blockern der NKG2D-Rezeptor-/NKG2D-Liganden-Interaktion bei Autoimmunerkrankungen
JP2008521814A (ja) * 2004-11-24 2008-06-26 シェーリング コーポレイション Dap−10およびその使用
WO2011130749A2 (en) 2010-04-16 2011-10-20 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-hsv receptors
US20130156808A1 (en) * 2011-11-22 2013-06-20 Stipan Jonjic Vaccine comprising beta-herpesvirus
EP2970490A4 (en) 2013-03-15 2017-04-26 Novelogics Biotechnology, Inc. Antibodies to mica and micb proteins
BR112016009465A8 (pt) 2013-10-28 2018-01-30 Univ Pittsburgh Commonwealth Sys Higher Education vetor de hsv oncolítico.
KR20180136435A (ko) 2016-01-27 2018-12-24 온코루스, 인크. 종양 살상형 바이러스 벡터 및 그의 용도
CN109475613B (zh) 2016-06-14 2024-02-20 匹兹堡大学-属高等教育联邦体系 使癌细胞对胞毒免疫细胞攻击敏感的nkg2d活化配体蛋白表达
AU2017290828A1 (en) 2016-06-30 2019-01-24 Virogin Biotech Canada Ltd Pseudotyped oncolytic viral delivery of therapeutic polypeptides
CA3040421A1 (en) 2016-10-19 2018-04-26 Novelogics Biotechnology, Inc. Antibodies to mica and micb proteins
US11612625B2 (en) 2017-07-26 2023-03-28 Oncorus, Inc. Oncolytic viral vectors and uses thereof
US11661447B2 (en) 2017-08-03 2023-05-30 The Cleveland Clinic Foundation Human β2-glycoprotein I expression
EP3731850A4 (en) 2017-12-29 2021-12-01 Oncorus, Inc. ONCOLYTIC VIRUS DELIVERY OF THERAPEUTIC POLYPEPTIDES
CN112285360B (zh) * 2020-09-23 2023-08-22 台州市第一人民医院 I-309在制备原发性干燥综合征诊断试剂或试剂盒中的应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US22239A (en) * 1858-12-07 Limekiln
US4311A (en) * 1845-12-16 William beebe
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
DE4118120A1 (de) 1991-06-03 1992-12-10 Behringwerke Ag Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US20030004311A1 (en) * 1997-06-18 2003-01-02 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030022239A1 (en) 1997-06-18 2003-01-30 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
ATE440951T1 (de) * 1997-12-17 2009-09-15 Serono Genetics Inst Sa Verlängerte cdns, die für sekretierte proteine kodieren
CA2315251A1 (en) * 1997-12-17 1999-06-24 Immunex Corporation Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
JP2003505082A (ja) 1999-07-26 2003-02-12 ジェネンテック・インコーポレーテッド 新規なポリヌクレオチドとその使用法
CA2491433A1 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20040034192A1 (en) 2000-01-06 2004-02-19 Seishi Kato Human proteins having hyprophobic domains and dnas encoding these proteins
US20040219521A1 (en) * 2000-01-21 2004-11-04 Tang Y. Tom Novel nucleic acids and polypeptides
US20040038339A1 (en) 2000-03-24 2004-02-26 Peter Kufer Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
US20050074754A1 (en) * 2000-04-27 2005-04-07 Shoichi Okubo Novel protein and use thereof
AU5943201A (en) 2000-05-03 2001-11-12 Amgen Inc Modified peptides as therapeutic agents
WO2002068615A2 (en) 2001-02-28 2002-09-06 Fred Hutchinson Cancer Research Center, Inc. Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives
US6821522B2 (en) * 2001-05-31 2004-11-23 The Regents Of The University Of California Tumor Therapy
US20060127894A1 (en) 2001-08-08 2006-06-15 Incyte Corporation Protein associated with cell growth, differentiation, and death
AU2002366951A1 (en) 2001-12-10 2003-07-09 Nuvelo,Inc. Novel nucleic acids and polypeptides
CN100358917C (zh) 2002-03-04 2008-01-02 上海睿星基因技术有限公司 肿瘤标志物及其用途
WO2004022706A2 (en) 2002-09-04 2004-03-18 The Trustees Of The University Of Pennsylvania Immune cell receptor ligand and immune cell receptor

Also Published As

Publication number Publication date
EP1451333A4 (en) 2005-03-30
WO2003029436A3 (en) 2003-11-13
PL373594A1 (en) 2005-09-05
EP1451333A2 (en) 2004-09-01
WO2003029436A2 (en) 2003-04-10
US7563450B2 (en) 2009-07-21
DE60232742D1 (de) 2009-08-06
US20030195337A1 (en) 2003-10-16
US8129167B2 (en) 2012-03-06
CA2462790A1 (en) 2003-04-10
MXPA04003057A (es) 2005-06-20
US20090274699A1 (en) 2009-11-05
JP2005523681A (ja) 2005-08-11
AU2002340118B2 (en) 2007-09-13
EP1451333B1 (en) 2009-06-24

Similar Documents

Publication Publication Date Title
DE60232742D1 (de) Ul16-bindungsprotein 4
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
IL210454A0 (en) Novel cytokine zcytor17 ligand
WO2003020756A3 (en) Hybrid and tandem expression of neisserial proteins
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
WO2004032877A3 (en) Compositions, organisms and methodologies employing a novel human kinase
EP2314604A3 (en) Nucleic acids coding for adhesion factors of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof
WO2004043403A3 (en) Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
DE69937570D1 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
EP0816504A3 (en) Platelet activating factor acetylhdrolase, and gene thereof
DE69619808D1 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
CY1111763T1 (el) ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51
IL139604A (en) Fibrinogen-beta chain derived peptide, compositions comprising same and use thereof
AU3711597A (en) A novel galanin receptor
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
WO2001068846A3 (en) Transcription activator of the cited family
WO2003091447A3 (en) D1-1 nucleic acids, polypeptides and related methods
TW342413B (en) Novel toxins isolated from Bracon Hebetor
MXPA01011563A (es) Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
SE0101519D0 (sv) Nucleic ACID
WO2003018806A1 (fr) Nouveau gene humain bmcc1
WO2001072842A3 (en) Human 7-transmembrane proteins and polynucleotides encoding the same
WO2004033638A3 (en) Compositions, organisms and methodologies employing a novel human kinase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties